Constitutionality of banning off-label use of drugs
When the FDA approved the sale of RU-486 in this country, the agency used a little known process historically reserved for life-saving drugs. Lars Noah described the process in his article, A Miscarriage in the Drug Approval Process?: Mifepristone Embroils the FDA in Abortion Politics. Since the approval of the drug, abortion providers have continued […]